Kamra corneal inlay

Deeper implantation depth for inlay may enhance visual performanceA comparative analysis suggests placement of a cornea inlay (Kamra, AcuFocus) has improved patient satisfaction, refractive stability, and visual results when placed at 250 μm or deeper in the cornea. Shallower implantation depths may be more prone to refractive instability and lower patient satisfaction.
Managing presbyopia heading into the year 2020Patients don’t have to wait for 2020 to achieve 20/20 vision at near without spectacles or contact lenses. Rather, the advancements we have seen just in the past few years should be enough to help manage their expectations.
Minimally invasive surgical solutions for presbyopia
Minimally invasive surgical solutions for presbyopiaPresbyopia, an age-related loss of accommodative amplitude of the eye resulting in near and intermediate vision deficits, begins to affect most people once they reach their early 40s.
New correction option for presbyopes
New correction option for presbyopesAt present we are limited with our ability to treat presbyopes. Sure, we have progressives and multifocal contact lenses; however, from a surgical standpoint, monovision corneal refractive surgery is limited, and clear lens extraction is often extreme for emmetropes.
Corneal inlay technology offers new advantagesCorneal inlays to correct refractive errors are not new—various materials have been tried for more than 50 years to correct blurred vision. The greatest barriers to success of corneal inlays have been a lack of biocompatibility with the cornea, the difficulty of placing them within the corneal stroma safely, and refractive predictably.
FDA approves AcuFocus corneal inlayThe FDA has approved AcuFocus’ corneal inlay product (KAMRA inlay.) The device is indicated to improve near vision by extending depth of focus in patients with presbyopia who have emmetropic refractions (+0.50 to –0.75 D).